Macquarie Group LTD Pmv Pharmaceuticals, Inc. Transaction History
Macquarie Group LTD
- $85.1 Billion
- Q2 2024
A detailed history of Macquarie Group LTD transactions in Pmv Pharmaceuticals, Inc. stock. As of the latest transaction made, Macquarie Group LTD holds 2,077 shares of PMVP stock, worth $3,115. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,077Holding current value
$3,115% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PMVP
# of Institutions
101Shares Held
43.4MCall Options Held
500Put Options Held
100-
Orbimed Advisors LLC San Diego, CA6.48MShares$9.71 Million0.25% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO2.8MShares$4.21 Million0.06% of portfolio
-
Sio Capital Management, LLC New York, NY2.71MShares$4.06 Million1.64% of portfolio
-
Euclidean Capital LLC New York, NY2.63MShares$3.94 Million0.54% of portfolio
-
Alkeon Capital Management LLC New York, NY2.35MShares$3.52 Million0.01% of portfolio
About PMV Pharmaceuticals, Inc.
- Ticker PMVP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,622,600
- Market Cap $68.4M
- Description
- PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...